Assessment of Heart Failure: Early Identification and Across the Spectrum


Speaker Name/Credentials

James L. Januzzi, Jr. MD, FACC, FESC
Hutter Family Professor of Medicine, Harvard Medical School; DeSanctis Endowed Clinical Scholar, Massachusetts General Hospital Cardiometabolic Trial Group, Harvard Clinical Research Institute

Estimated Time of Talk

40 minutes


This webcast will cover identification, assessment, biomarkers and treatment considerations for heart failure.

Learning Objectives

  • Identify biomarkers that may help to recognize and manage patients with heart failure
  • Understand how to optimally use natriuretic peptides in the acute diagnosis of heart failure

Target Audience                                             

Primary Care Physicians, Internal Medicine and, Specialists

Conflicts of Interest

Grants: Roche Diagnostics, Critical Diagnostics, Singulex, Thermo Fisher
Consulting and/or CEC participation: Roche Diagnostics, Critical Diagnostics, Amgen, Zensun, Novartis, Radiometer, Boeringer-Ingelheim

Share this: